CRISPR knockout/knockin
Crispr News
-
For sickle cell patients, a CRISPR cure could mean infertility - STAT - STATDecember 6, 2023
-
Siddhartha Mukherjee: CRISPR, AI, and cloning could transform the human race - GZERO MediaDecember 5, 2023
-
CRISPR (CRSP) to Focus on Next-Generation CAR T Pipeline - Yahoo FinanceDecember 5, 2023
-
CRISPR (CRSP) to Focus on Next-Generation CAR T Pipeline - Zacks Investment ResearchDecember 5, 2023
-
Eligo Bioscience Raises $30M in Series B Financing to Develop CRISPR-Based Acne Drug - Precision Medicine OnlineDecember 5, 2023
-
CRISPR Therapeutics ventures into autoimmune disorder CAR T development - Pharmaceutical TechnologyDecember 5, 2023
-
CRISPR Reorganizes CAR-T Pipeline Ahead of FDA’s Landmark Decision - BioSpaceDecember 5, 2023
-
First CRISPR Sickle Cell Patient ‘Reborn’: FDA Approval Expected - ForbesDecember 5, 2023
-
New enzyme allows CRISPR technologies to accurately target almost all human genes - Phys.orgDecember 5, 2023
-
CRISPR Therapeutics' Gene-Edited Oncology Pipeline To Focus On Expanded Use In Autoimmune Diseases - CRIS - BenzingaDecember 5, 2023
-
Better Growth Stock: CRISPR Therapeutics vs. Invitae - The Motley FoolDecember 5, 2023
-
Viewpoint: Skeptical take on newly-approved CRISPR sickle cell treatment tool - Genetic Literacy ProjectDecember 5, 2023
-
Crispr gene editing technology could transform medicine | FT Tech - Financial TimesDecember 5, 2023
-
CRISPR Tx cuts cancer programs, expands into autoimmune disease - FierceBiotechDecember 5, 2023
-
CRISPR Therapeutics (CRSP) CTX110 and CTX130 provided important proof of concept - StreetInsider.comDecember 4, 2023
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.